Skip to main content

February 2020 Vol 13, No 1

Perspectives
Corporate Culture of Health: Elusive and Expensive
David B. Nash, MD, MBA
Read More
Original Research, Practice Management
Association Between Formulary Coverage and Use of Abuse-Deterrent Prescription Opioids, Risk for Abuse or Overdose, and Associated Healthcare Resource Utilization
Allison Petrilla, MPH; Elizabeth Marrett, MPH; Xian Shen, PhD, MS, BS; Winghan Jacqueline Kwong, PharmD, PhD; Edmund Pezalla, MD, MPH
Stakeholder Perspective
Abuse-Deterrent Formulations of Prescription Opioids: A Missed Opportunity to Address the Current Opioid Crisis?
Atheer A. Kaddis, PharmD
Read More
Original Research, Pulmonary
Medication Use Before and After Hospitalization for Chronic Obstructive Pulmonary Disease in a Cohort of Elderly Patients with a Medicare Advantage Plan
Qingqing Xu, MS; Sarah S. Laxa, PharmD; Omar Serna, PharmD, BCACP; Sujit S. Sansgiry, MS, PhD
Stakeholder Perspective
Improving Medication Use for Chronic Diseases by Reducing Costs, Increasing Patient Adherence
F. Randy Vogenberg, PhD, FASHP
Read More

Results 1 - 3 of 3